BAKER BROS. ADVISORS LP 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-24 1:43 pm Purchase | 2023-11-21 | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BAKER BROS. ADVISORS LP | 2,365,472 19.990% | 167,553 (+7.62%) | Filing |
| 2023-05-05 4:24 pm Purchase | 2023-05-05 | 13D | Bellicum Pharmaceuticals, Inc. BLCM | BAKER BROS. ADVISORS LP | 2,197,919 19.990% | 2,197,919 (New Position) | Filing |